Cogent Biosciences (COGT) Return on Sales: 2017-2020
Historic Return on Sales for Cogent Biosciences (COGT) over the last 3 years, with Sep 2020 value amounting to -2.95%.
- Cogent Biosciences' Return on Sales rose 93.00% to -2.95% in Q3 2020 from the same period last year, while for Sep 2020 it was -2.95%, marking a year-over-year increase of 93.00%. This contributed to the annual value of -10.42% for FY2020, which is 901.00% down from last year.
- Per Cogent Biosciences' latest filing, its Return on Sales stood at -2.95% for Q3 2020, which was down 203.73% from -0.97% recorded in Q2 2020.
- Over the past 5 years, Cogent Biosciences' Return on Sales peaked at -0.97% during Q2 2020, and registered a low of -4.10% during Q3 2018.
- Its 3-year average for Return on Sales is -2.88%, with a median of -3.40% in 2019.
- As far as peak fluctuations go, Cogent Biosciences' Return on Sales tumbled by 70bps in 2019, and later spiked by 276bps in 2020.
- Cogent Biosciences' Return on Sales (Quarterly) stood at -3.08% in 2017, then tumbled by 50bps to -3.58% in 2018, then skyrocketed by 216bps to -1.42% in 2019, then surged by 93bps to -2.95% in 2020.
- Its last three reported values are -2.95% in Q3 2020, -0.97% for Q2 2020, and -0.99% during Q1 2020.